Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

INDUSTRY 9 OTHER 7 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Specimen Handling 68 Magnetic Resonance Spectroscopy 53 Cyclophosphamide 45 Vincristine 38 Radiotherapy 31 Radiation 31 Cisplatin 31 Carboplatin 30 Dexamethasone 27 Etoposide 26 Doxorubicin 25 Biopsy 25 daratumumab 17 Radiotherapy, Intensity-Modulated 17 Prednisone 17 Platinum 16 Paclitaxel 16 Irinotecan 16 Cytarabine 16 durvalumab 15 Gemcitabine 15 1,2-diaminocyclohexaneplatinum II citrate 15 Observation 14 Methotrexate 14 Leucovorin 14 Docetaxel 14 Lenalidomide 13 X-Rays 12 Watchful Waiting 12 Rituximab 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Hydroxyurea × 1 year × Clear all

NCT06326190 2025-09-16

LUMEN-1

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Recruiting

Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡